About Us

VISION

Active Needle Technology to become a gold standard in ultrasound-guided needle interventional procedures.

Active Needle Technology Ltd. is an innovative, pre-revenue medical device company. The company aims to address the universal problem of needle placement errors in ultrasound-guided needle interventional procedures through commercialisation of its award-winning “needle actuating device”, originally developed at the University of Dundee. The technology enables precision needle targeting and has the potential to allow clinicians to perform these procedures safely, efficiently and cost-effectively benefitting patients and healthcare providers.

The technology is the outcome of the research work carried out by Dr. Muhammad Sadiq, a biomedical engineer and RSE enterprise fellow, and Prof. Graeme McLeod, a consultant anaesthetist at Ninewells Hospital and the University of Dundee.

The adoption of Active Needle’s technology in clinical practice offers the potential of significant health economic and clinical benefits to drive shared value for investors, patients, clinicians and healthcare providers and payers.

MARKET ANALYSIS

Unsuccessful biopsy, due to inaccurate needle placement, is all too common and the attendant costs of a repeat biopsy (on another day), with costs of analysis and administration imposes a significant burden on healthcare systems and patients alike.

Active Needle Technology Ltd. has conducted an independent market survey, involving expert clinicians from the EU and USA to validate the problems and identify the market need for the Active Needle’s proposition.

Besides validating the universal problems of poor visibility and deflection of needle tip, the participating clinicians validated the adverse effects i.e. pain and tissue trauma, that occur as a direct result of needle misplacement. It was noted that only 10% of the participating clinicians could always (confidently) visualise the needle while a clear majority of the clinicians, 90% believed that increased visibility of standard needle can significantly reduce the procedure time and complications. Furthermore, all clinicians showed interested in using the Active Needle’s Technology themselves (90%) or for colleagues in their practice (10%).

PRIMARY PROBLEM

SECONDARY PROBLEM

ANT IN YOUR PRACTICE

MEET OUR TEAM

Ian Quirk
CEO

Ian Quirk is the Founder and CEO of Active Needle Technology Ltd. Ian has more than 20 years of experience in the medical device industry,...

Dr. Muhammad Sadiq (PhD)
Senior Technical Officer

Muhammad Sadiq is the Founder and Senior Technical Officer of Active Needle Technology Ltd. Muhammad is an RSE Enterprise Fellow and the inventor of...

David Tuch (PhD)
Non-Executive Director

Dr. David Tuch is the Founder and CEO of Lightpoint Medical Ltd.. He has more than a decade of experience in the medical imaging and...

Mike Irvine, PhD
Director of Product Development

Dr. Mike Irvine brings more than 30 years of healthcare product development experience to Active Needle Technology. Mike has worked with the founding team...

Mike Hawley
Chairman

Michael has a passion for turnaround, transformation and change in the start-up and SME segments. Having started his early career in chemical engineering he...

Graeme Smith
Non-Executive Director

Graeme joined the board of Active Needle Technology near its inception and is bringing 25 years of medical device experience to the company. His...